PROGRAM EVALUATION

Please provide the following information:

FIRST NAME

LAST NAME

PROFESSION

SPECIALTY

COUNTRY

E-MAIL



Question 1: Please rate the presentations according to the following scale by choosing the appropriate numbers in the table below.

Diabetic Retinopathy and the Evolution of Eye Screening Technology
David Kerr, MB, ChB, DM, FRCPE, FRCP

Was the topic selected appropriate for the audience?
Relevance to My Practice
Balanced and Without Commercial Interest
Was the presentation clear, organized and understandable?



The New Science of AI Screening
Jennifer I Lim, MD, FARVO

Was the topic selected appropriate for the audience?
Relevance to My Practice
Balanced and Without Commercial Interest
Was the presentation clear, organized and understandable?



AI Screening in Practice: Implementation Data and Endpoints
Steven Yeh, MD, FASRS

Was the topic selected appropriate for the audience?
Relevance to My Practice
Balanced and Without Commercial Interest
Was the presentation clear, organized and understandable?



Presentation /Speaker
Question & Answer Session
All faculty

Was the topic selected appropriate for the audience?
Relevance to My Practice
Balanced and Without Commercial Interest
Was the presentation clear, organized and understandable?



Question 2: Please indicate how well you think the learning objectives were covered according to the following scale by choosing the appropriate numbers in the table below.

Learning Objective 1
Gain a better understanding of the latest knowledge of diabetic retinopathy and the evolution of eye screening technology

Objective Was Met
Confidence in Personal Ability to Achieve the Objective BEFORE the Presentations
Confidence in Personal Ability to Achieve the Objective AFTER the Presentations



Learning Objective 2
Learn about the new science, advances, and benefits of Artificial Intelligence eye screening

Objective Was Met
Confidence in Personal Ability to Achieve the Objective BEFORE the Presentations
Confidence in Personal Ability to Achieve the Objective AFTER the Presentations



Learning Objective 3
Obtain practical knowledge into how AI screening is being implemented in practice based on clinical data results

Objective Was Met
Confidence in Personal Ability to Achieve the Objective BEFORE the Presentations
Confidence in Personal Ability to Achieve the Objective AFTER the Presentations



Question 3: Did this program increase or expand your knowledge of the topics presented by the speakers?



Question 4: Based on the information presented, do you intend to apply the knowledge gained to your clinical practice?

Please explain your answer.

Question 5: Please include any other comments you may have, including suggestions for future programs.






This program is sponsored by the Worldwide Initiative for Diabetes Education and supported by an educational grant from Eyenuk, Inc.



A Worldwide Initiative for Diabetes Education for Health Care Professionals